MAGAININ PHARMACEUTICALS INC
5, 1998-02-13
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: MAGAININ PHARMACEUTICALS INC, 5, 1998-02-13
Next: MAGAININ PHARMACEUTICALS INC, 5, 1998-02-13



<PAGE>   1
                                               ----------------------------
                                                      OMB APPROVAL        
                                               ----------------------------
- ------                                         OMB Number: 3235-0362   
FORM 5                                         Expires:  September 30, 1998  
- ------                                         Estimated average burden  
                                               hours per response .... 1.0
                                               ----------------------------

/ / Check box if no             UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    longer subject to                       WASHINGTON, D.C. 20549              
    Section 16. Form                                                           
    4 or Form 5             ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
    obligations may                                                            
    continue.                 Filed pursuant to Section 16(a) of the Securities 
    See Instruction 1(b).     Exchange Act of 1934, Section 17(a) of the Public
/ / Form 3 Holdings           Utility Holding Company Act of 1935 or Section
    Reported                  30(f) of the Investment Company Act of 1940
/ / Form 4                                         
    Transactions                                                      
    Reported                                                                

<TABLE>
<S>                             <C>          <C>                        <C>                <C>          <C>            <C>   
- ------------------------------------------------------------------------------------------------------------------------------------
 1. Name and Address of Reporting Person*    2. Issuer Name and Ticker or Trading Symbol   6. Relationship of Reporting Person(s) to
  Canavan         Bernard                       Magainin Pharmaceuticals Inc.-MAGN            Issuer (Check all applicable)
- -------------------------------------------------------------------------------------------     x  Director         10% Owner
  (Last)          (First)          (Middle)  3. IRS or Social Security  4. Statement for      ----              ---
 c/o Magainin Pharmaceuticals Inc.              Number of Reporting        Month/Year             Officer (give    Other (specify
 5110 Campus Drive                              Person (Voluntary)           12/97            ----        title ---       below)
- -------------------------------------------                             ------------------                below)
                 (Street)                                               5. If Amendment,   7. Individual or Joint/Group Reporting
                                                                           Date of Original         (Check applicable line)
                                                                           (Month/Year)           Form Filed by One Reporting
                                                                                               x    Person
                                                                                              ----
                                                                                                  Form Filed by More than One
 Plymouth Meeting,    PA             19462                                                    ----  Reporting Person
- -------------------------------------------    -------------------------------------------------------------------------------------
  (City)           (State)           (Zip)     TABLE 1 -- NON-DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENEFICIALLY OWNED
- ------------------------------------------------------------------------------------------------------------------------------------
 1. Title of Security          2. Trans-   3. Transac-  4. Securities Acquired (A)  5. Amount of          6. Ownership   7. Nature
    (Instr. 3)                    action      tion         or Disposed of (D)          Securities            Form:          of In-
                                  Date        Code         (Instr. 3, 4 and 5)         Beneficially          Direct         direct
                                 (Month/      (Instr. 8)                               Owned at end of       (D) or         Benefi-
                                  Day/                                                 Issuer's Fiscal       Indirect       cial
                                  Year)                ----------------------------    Year (Instr. 3        (I)            Owner-
                                                       Amount    (A) or      Price     and 4)                (Instr. 4)     ship
                                                                  (D)                                                       (Instr.
                                                                                                                            4)     

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

*If the form is filed by more than one reporting person, see Instruction 4(b)(v).

</TABLE>

<PAGE>   2
<TABLE>
<CAPTION>
 
FORM 5 (CONTINUED)        TABLE II -- DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENEFICIALLY OWNED
                                  (E.G., PUTS, CALL, WARRANTS, OPTIONS, CONVERTIBLE SECURITIES)

<S>                       <C>          <C>        <C>         <C>              <C>             <C>                   <C>          
- ------------------------------------------------------------------------------------------------------------------------------------
1. Title of Derivative    2. Conver-   3. Trans-  4. Trans-   5. Number of     6. Date Exer-   7. Title and Amount   8. Price     
   Security                  sion or      action     action      Derivative       cisable and     of Underlying         of        
   (Instr. 3)                Exercise     (Month/    Code        Securities Ac-   Expiration      Securities            Deriv-    
                             Price of     Day/      (Instr. 8)   quired (A) or    Date            (Instr. 3 and 4)      ative     
                             Deriv-       Year)                  Disposed of (D)  (Month/Day/                           Secur-    
                             ative                               (Instr. 3, 4,    Year)                                 ity       
                             Security                            and 5)                                                 (Instr. 5)
                                                                               -----------------------------------             
                                                                               Date     Expira-            Amount or            
                                                               --------------- Exer-    tion       Title   Number of            
                                                                (A)     (D)    cisable  Date               Shares               
- ------------------------------------------------------------------------------------------------------------------------------------
Option to buy                 $7.630     5/7/97        A          5,000        5/7/98+  5/7/2007   Common  5,000         0    
                                                                                                   Stock     
- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- ------------------------------------------------------------------------------------------------------------------------------------

- -------------------------------------------------------------------------------------------------------
<C>                    <C>                         <C>                              
9. Number of           10. Ownership               11. Nature of                              
   Derivative              of Derivative               Indirect                     
   Securities              Security:                   Beneficial                   
   Beneficially            Direct (D)                  Ownership                    
   Owned at End            or Indirect (l)             (Instr. 4)                   
   of Year                 (Instr. 4)                                               
   (Instr. 4)                                                                       
                                                    
- --------------------------------------------------------------------------
 5,000                         D
- --------------------------------------------------------------------------

- --------------------------------------------------------------------------

- --------------------------------------------------------------------------

- --------------------------------------------------------------------------

- --------------------------------------------------------------------------

- --------------------------------------------------------------------------
Explanation of Responses:
+    Options exercisable at the rate of 25% of such option on each of the first four anniversary dates of the date of grant, which
     was May 7, 1997.
 
**   Intentional misstatements or omissions of facts constitute Federal Criminal Violations.     /s/ Bernard Canavan         2/11/98
     See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).                                               ------------------------------- -------
                                                                                             **Signature of Reporting Person   Date
                                         

Note. File three copies of this Form, one of which must be manually signed.                                         
      If space provided is insufficient, See Instruction 6 for procedure.                                           

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the
form displays a currently valid OMB Number. 
</TABLE>                                                                    

                                     Page 2




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission